Today, we approved the first vaccine approved for use in pregnant individuals to prevent lower respiratory tract disease (LRTD) and severe LRTD caused by respiratory syncytial virus (RSV) in infants from birth through 6 months of age. https://t.co/FjEJI1vyZS
@FChaconCR Ojalá que los ticos podamos "contribuir" con el cambio de chip que nos toca, porque el cambio real y duradero se consigue entre todos. @presidenciacr@RodrigoChavesR
@neosatyan@SankaranDeepika@KapadiaNeo Probably not all neonates requiring resuscitation will be candidates for delayed cord clamping, and if we use higher saturation goals it could mean exposing more neonates to oxygen